QALY-time: experts' view on the use of the quality-adjusted LIFE year in COST-effectiveness analysis in palliative care
- PMID: 32678021
- PMCID: PMC7364560
- DOI: 10.1186/s12913-020-05521-x
QALY-time: experts' view on the use of the quality-adjusted LIFE year in COST-effectiveness analysis in palliative care
Abstract
Background: The Quality-Adjusted Life Year (QALY) is internationally recognized as standard metric of health outcomes in cost-effectiveness analyses (CEAs) in healthcare. The ongoing debate concerning the appropriateness of its use for decision-making in palliative care has been recently mapped in a review. The aim was to report on and draw conclusions from two expert meetings that reflected on earlier mapped issues in order to reach consensus, and to advise on the QALY's future use in palliative care.
Methods: A nominal group approach was used. In order to facilitate group decision making, three statements regarding the use of the QALY in palliative care were discussed in a structured way. Two groups of international policymakers, healthcare professionals and researchers participated. Data were analysed qualitatively using inductive coding.
Results: 1) Most experts agreed that the recommended measurement tool for the QALYs 'Q' component, the EuroQol-5D (EQ-5D), is inappropriate for palliative care. A more sensitive tool, which might be based on the capabilities approach, could be used or developed. 2) Valuation of time should be incorporated in the 'Q' part, leaving the linear clock time in the 'LY' component. 3) Most experts agreed that the QALY, in its current shape, is not suitable for palliative care.
Conclusions: 1) Although the EQ-5D does not suffice, a generic tool is needed for the QALY. As long as no suitable alternative is available, other tools can be used besides or serve as basis for the EQ-5D because of issues in conceptual overlap. 2) Future research should further investigate the valuation of time issue, and how best to integrate it in the 'Q' component. 3) A generic outcome measure of effectiveness is essential to justly allocate healthcare resources. However, experts emphasized, the QALY is and should be one of multiple criteria for choices in the healthcare insurance package.
Keywords: Cost-benefit analysis; Focus groups (MeSH); Palliative medicine; Quality-Adjusted life years.
Conflict of interest statement
The authors declare that they have no competing interests.
References
-
- EuroStat . Population structure and ageing. 2017.
-
- EuroStat . A look at the lives of the elderly in the EU today. 2017.
-
- Worldbank . Health expenditure, total (% of GDP): The World Bank. 2017.
-
- Bodenheimer T. High and rising health care costs. Part 2: technologic innovation. Ann Intern Med. 2005;142(11):932–937. - PubMed
-
- WHO . The world health report: 2006: working together for health. 2006. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials